| 1 |
34347217 | Association between ABCC2 polymorphism and hematological toxicity in patients with esophageal cancer receiving platinum plus 5-fluorouracil therapy. | 2022 Jan |
4 |
| 2 |
29660381 | ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2. | 2018 Jul 28 |
1 |
| 3 |
28442702 | Effect of GSTP1 and ABCC2 Polymorphisms on Treatment Response in Patients with Advanced Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy: A Study in a Chinese Uygur Population. | 2017 Apr 26 |
1 |
| 4 |
28982859 | Changes in the Expression of Various Transporters as Influencing Factors of Resistance to Cisplatin. | 2017 Oct |
1 |
| 5 |
26816351 | ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients. | 2016 Apr |
5 |
| 6 |
27014726 | Data showing the circumvention of oxaliplatin resistance by vatalanib in colon cancer. | 2016 Jun |
2 |
| 7 |
27487151 | ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients. | 2016 Aug 23 |
1 |
| 8 |
27590272 | Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients. | 2016 Sep 2 |
5 |
| 9 |
27748801 | Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells. | 2016 Dec |
1 |
| 10 |
26131551 | Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles. | 2015 |
7 |
| 11 |
24641901 | Transgenic expression of the human MRP2 transporter reduces cisplatin accumulation and nephrotoxicity in Mrp2-null mice. | 2014 May |
2 |
| 12 |
20943283 | Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients. | 2011 May |
2 |
| 13 |
21687948 | 'Genetic profiling' and ovarian cancer therapy (review). | 2011 Sep-Oct |
1 |
| 14 |
19568750 | MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer. | 2010 Feb |
4 |
| 15 |
18214043 | Immunohistochemical expression of MRP2 and clinical resistance to platinum-based chemotherapy in small cell lung cancer. | 2007 Nov-Dec |
4 |
| 16 |
16213010 | MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma. | 2006 Feb |
4 |
| 17 |
17145840 | ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome. | 2006 Dec 1 |
1 |
| 18 |
15688364 | Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells. | 2005 Jun 20 |
5 |
| 19 |
12839578 | Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin. | 2003 Jul |
9 |
| 20 |
11332988 | Kinetic characterization of ribozymes directed against the cisplatin resistance-associated ABC transporter cMOAT/MRP2/ABCC2. | 2001 Mar |
3 |